| 2026-03-25 |
详情>>
内部人交易：
Yu Siying等共交易19笔
|
| 2026-03-19 |
详情>>
业绩披露：
2026年三季报(累计)每股收益4.33元,归母净利润804.28亿元,同比去年增长-31.31%
|
| 2026-03-19 |
财报披露：
美东时间 2026-03-19 盘前发布财报
|
| 2026-02-04 |
详情>>
股本变动：
变动后总股本238741.28万股
变动原因 ▼▲
|
| 2025-12-04 |
详情>>
业绩披露：
2026年中报每股收益3.45元,归母净利润641.06亿元,同比去年增长-5.92%
|
| 2025-08-29 |
详情>>
业绩披露：
2026年一季报每股收益2.32元,归母净利润431.16亿元,同比去年增长77.66%
|
| 2025-08-06 |
股东大会：
将于2025-09-25召开股东大会
会议内容 ▼▲
- 1.Share Issuance Mandate – grant the Board a general mandate, until the next annual general meeting of the Company, to issue, allot and/or otherwise deal with additional Ordinary Shares not exceeding 10% of the number of issued Ordinary Shares (excluding any Treasury Shares) as of the date of the General Meeting.
2.Share Repurchase Mandate – grant the Board a general mandate, until the next annual general meeting of the Company, to repurchase Ordinary Shares not exceeding 10% of the number of issued Ordinary Shares of the Company (excluding any Treasury Shares) as of the date of the General Meeting.
3.Election of Directors – elect, as separate resolutions, each of Eddie Yongming WU, Jerry YANG, Wan Ling MARTELLO and Albert Kong Ping NG as directors, to serve until the Company’s 2028 annual general meeting.
4.Appointment of Independent Registered Public Accounting Firm – appoint PricewaterhouseCoopers Zhong Tian LLP and PricewaterhouseCoopers as the Company’s U.S. and Hong Kong independent registered public accounting firms, respectively, until the next annual general meeting of the Company.
|
| 2025-06-26 |
详情>>
业绩披露：
2025年年报每股收益6.89元,归母净利润1294.70亿元,同比去年增长62.36%
|
| 2025-06-26 |
详情>>
业绩披露：
2023年年报每股收益3.46元,归母净利润725.09亿元,同比去年增长17.03%
|
| 2025-02-20 |
详情>>
业绩披露：
2025年三季报(累计)每股收益6.20元,归母净利润1170.88亿元,同比去年增长53.11%
|
| 2024-11-29 |
详情>>
业绩披露：
2025年中报每股收益3.58元,归母净利润681.43亿元,同比去年增长9.84%
|
| 2024-08-15 |
详情>>
业绩披露：
2025年一季报每股收益1.26元,归母净利润242.69亿元,同比去年增长-29.31%
|
| 2024-07-05 |
股东大会：
将于2024-08-22召开股东大会
会议内容 ▼▲
- 1.To amend and restate the Company’s Memorandum and Articles of Association. The full text of the amended and restated Memorandum and Articles of Association is set out in Exhibit A to the proxy statement.
2.To grant a general mandate to the Board to issue, allot and/or otherwise deal with additional Ordinary Shares (including in the form of ADSs) of the Company (including any sale or transfer of Treasury Shares) during the Issuance Period not exceeding 10% of the number of issued Ordinary Shares of the Company (excluding Treasury Shares) as of the date of passing of this ordinary resolution. Any additional Ordinary Shares to be issued or allotted pursuant to this mandate shall not be at a discount of more than 10% to the Benchmarked Price as detailed in the proxy statement.
3.To grant a general mandate to the Board to repurchase Ordinary Shares (including in the form of ADSs) of the Company during the Repurchase Period not exceeding 10% of the number of issued Ordinary Shares of the Company (excluding Treasury Shares) as of the date of passing of this ordinary resolution (the “Share Repurchase Mandate”). An explanatory statement regarding the Share Repurchase Mandate is set out in Exhibit B to the proxy statement.
4.To adopt the 2024 Equity Incentive Plan of the Company and the Service Provider Sub-limit referred thereto. A summary of the 2024 Equity Incentive Plan is set out in Exhibit C to the proxy statement.
5.To elect each of Joseph C. TSAI, J. Michael EVANS, Weijian SHAN and Irene Yun-Lien LEE as directors.
6.To ratify and approve the appointments of PricewaterhouseCoopers Zhong Tian LLP and PricewaterhouseCoopers as the U.S. and Hong Kong independent registered public accounting firms of the Company, respectively, for the fiscal year ending March 31, 2025 and until the conclusion of the next annual general meeting of the Company.
|
| 2024-05-23 |
详情>>
业绩披露：
2024年年报每股收益3.95元,归母净利润797.41亿元,同比去年增长9.97%
|
| 2024-02-07 |
详情>>
业绩披露：
2024年三季报(累计)每股收益3.76元,归母净利润764.71亿元,同比去年增长56.09%
|
| 2023-08-16 |
股东大会：
将于2023-09-28召开股东大会
会议内容 ▼▲
- 1.To elect three directors, further details of which are set out in the proxy statement.
2.To ratify the appointments of PricewaterhouseCoopers Zhong Tian LLP and PricewaterhouseCoopers as the U.S. and Hong Kong independent registered public accounting firms of the Company, respectively, for the fiscal year ending March 31, 2024.
|
| 2022-08-08 |
股东大会：
将于2022-09-30召开股东大会
会议内容 ▼▲
- 1.To consider and, if thought fit, pass the following resolutions as ordinary resolutions:
Proposal No. 1:To elect six directors, further details of which are set out in the proxy statement.
Proposal No. 2:To ratify the appointment of PricewaterhouseCoopers as the independent registered public accounting firm of the Company for the fiscal year ending March 31, 2023.
2.To consider and transact such other business as may properly come before the General Meeting or any adjournment or adjournments thereof.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-08-11 |
股东大会：
将于2021-09-17召开股东大会
会议内容 ▼▲
- 1.To consider and, if thought fit, pass the following resolutions: To elect three directors.
2.To consider and, if thought fit, pass the following resolutions: To ratify the appointment of PricewaterhouseCoopers as the independent registered public accounting firm of the Company for the fiscal year ending March 31, 2022.
3.To consider and transact such other business as may properly come before the General Meeting or any adjournment or adjournments thereof.
|
| 2020-08-25 |
股东大会：
将于2020-09-30召开股东大会
会议内容 ▼▲
- 1.To amend and restate the Company’s Memorandum and Articles of Association to expressly permit completely virtual shareholders’ meetings and reflect such updates as detailed in the proxy statement and set forth in Exhibit A thereto.
2.To elect three directors.
3.To ratify the appointment of PricewaterhouseCoopers as the independent registered public accounting firm of the Company for the fiscal year ending March 31, 2021.
4.To consider and transact such other business as may properly come before the General Meeting or any adjournment or adjournments thereof.
|
| 2019-06-17 |
股东大会：
将于2019-07-15召开股东大会
会议内容 ▼▲
- 1.To effect an increase in the number of authorized Ordinary Shares to 32,000,000,000 and a one-to-eight share subdivision of the Company’s Ordinary Shares.
2.To elect four directors.
3.To ratify the appointment of PricewaterhouseCoopers as the independent registered public accounting firm of the Company.
4.To consider and transact such other business as may properly come before the AGM or any adjournment or adjournments thereof.
|
| 2017-10-18 |
股东大会：
将于2017-10-18召开股东大会
|
| 2016-10-13 |
股东大会：
将于2016-10-13召开股东大会
|
| 2015-09-09 |
股东大会：
将于2015-10-08召开股东大会
会议内容 ▼▲
- 1.To consider and, if thought fit, pass the following resolutions:①To elect five directors.②To ratify the appointment of Pricewaterhouse Coopers as the independent registered public accounting firm of the Company.
2.To consider and transact such other business as may properly come before the AGM or any adjournments or adjournments thereof.
|